ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 78 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $23,000 | -82.7% | 10,484 | -6.6% | 0.00% | -100.0% |
Q4 2021 | $133,000 | -25.7% | 11,222 | -2.9% | 0.00% | 0.0% |
Q3 2021 | $179,000 | -16.4% | 11,558 | +9.9% | 0.00% | 0.0% |
Q2 2021 | $214,000 | +54.0% | 10,513 | +72.4% | 0.00% | – |
Q1 2021 | $139,000 | -14.2% | 6,098 | +3.9% | 0.00% | -100.0% |
Q4 2020 | $162,000 | – | 5,868 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 2,320,381 | $2,808,000 | 4.30% |
Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $899,000 | 0.45% |
Vivo Capital, LLC | 3,547,030 | $4,292,000 | 0.43% |
TANG CAPITAL MANAGEMENT LLC | 1,547,710 | $1,873,000 | 0.28% |
Newtyn Management, LLC | 962,088 | $1,164,000 | 0.22% |
EcoR1 Capital, LLC | 3,948,360 | $4,778,000 | 0.16% |
Boxer Capital, LLC | 1,526,048 | $1,847,000 | 0.12% |
Novo Holdings A/S | 1,950,000 | $2,360,000 | 0.12% |
HHLR ADVISORS, LTD. | 2,365,064 | $2,862,000 | 0.06% |
SILVERARC CAPITAL MANAGEMENT, LLC | 58,392 | $71,000 | 0.02% |